Maria Palabougiouki
Overview
Explore the profile of Maria Palabougiouki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tragiannidis A, Antari V, Tsotridou E, Sidiropoulos T, Kaisari A, Palabougiouki M, et al.
Hematol Rep
. 2024 Oct;
16(4):579-584.
PMID: 39449299
Despite the progress achieved regarding survival rates in childhood acute lymphoblastic leukemia (ALL), relapsed or refractory disease still poses a therapeutic challenge. Inotuzumab ozogamicin is a CD22-directed monoclonal antibody conjugated...
2.
Papadopoulou M, Panagopoulou P, Paramera E, Pechlivanis A, Virgiliou C, Papakonstantinou E, et al.
Diagnostics (Basel)
. 2024 Apr;
14(7).
PMID: 38611595
Introduction: Acute lymphoblastic leukemia (ALL) is the most prevalent childhood malignancy. Despite high cure rates, several questions remain regarding predisposition, response to treatment, and prognosis of the disease. The role...
3.
Kourti M, Papakonstantinou E, Papagianni A, Arsos G, Ioannidou M, Pantoleon A, et al.
J Pediatr Hematol Oncol
. 2023 Jan;
45(6):322-326.
PMID: 36716084
Aim of this study was to evaluate the long-term therapeutic outcome and treatment-related complications in Hodgkin disease. We reviewed the medical records of 93 patients diagnosed with classic Hodgkin lymphoma,...
4.
Bangeas A, Protonotariou E, Hatzipantelis E, Palabougiouki M, Ioannidou M, Skoura L, et al.
Cardiovasc Hematol Agents Med Chem
. 2022 Nov;
21(3):193-201.
PMID: 36437726
Background/aim: Infections are a major cause of morbidity and mortality in children with haematologic malignancies and solid tumors as well as those undergoing hematopoietic stem cell transplantation (HSCT). The purpose...
5.
Markantonatou A, Tragiannidis A, Galani V, Doganis D, Antoniadi K, Tsipou H, et al.
J Fungi (Basel)
. 2021 Jun;
7(5).
PMID: 34062951
An audit based on a specific questionnaire was attempted, in order to investigate the mycology laboratory diagnostic capacity for invasive fungal diseases (IFDs) in Greek Paediatric Haematology-Oncology departments/units. The study...
6.
Kazakou N, Vyzantiadis T, Gambeta A, Vasileiou E, Tsotridou E, Kotsos D, et al.
Curr Med Mycol
. 2021 Feb;
6(2):37-42.
PMID: 33628980
Background And Purpose: Invasive fungal infections (IFIs) are a major cause of morbidity and mortality in immunocompromised children. The purpose of our study was to evaluate the incidence of IFIs...
7.
Kyriakidis I, Palabougiouki M, Vasileiou E, Tragiannidis A, Stamou M, Moudiou T, et al.
Turk Pediatri Ars
. 2019 Aug;
54(2):129-132.
PMID: 31384149
Both biliary atresia and hemoglobinopathies have been associated with a higher incidence of bloodstream infections. We hereby present the case of a female infant of Nigerian descent with extrahepatic biliary...